Clinical Study Unit

The Clinical Study Unit (CSU) is the internal clinical operations division of Sanofi, responsible for the planning, execution, and management of clinical trials across the company's global portfolio. The CSU operates as a specialized internal CRO-like entity, ensuring that clinical research is conducted in compliance with international regulatory standards and Good Clinical Practice (GCP). It manages a diverse pipeline spanning immunology, oncology, rare diseases, and vaccines, including high-profile programs like Dupixent and Sarclisa. By maintaining local expertise in various geographic regions, the CSU facilitates patient recruitment and site management to accelerate the delivery of new therapies to market.